ITGAM and neoplasm: We previously reported that low doses of diverse chemotherapeutic drugs, which are unable to control tumor growth, selectively affect the numbers of circulating CD11b+Ly6G−Ly6Chigh cells and enhance the efficacy of adoptive cell therapy (ACT)9.